CRISPR Therapeutics AG
Utility Patent Applications
Last updated:
List of all CRISPR Therapeutics AG patents 98 in total
| Status | Patent |
|---|---|
Application | Utility: UNIVERSAL DONOR CELLS Filling date: 13 Sep 2025 Issue date: 11 Mar 2021 |
Application | Utility: UNIVERSAL DONOR CELLS Filling date: 13 Sep 2025 Issue date: 11 Mar 2021 |
Application | Utility: UNIVERSAL DONOR CELLS Filling date: 13 Sep 2025 Issue date: 11 Mar 2021 |
Application | Utility: UNIVERSAL DONOR CELLS Filling date: 13 Sep 2025 Issue date: 11 Mar 2021 |
Application | Utility: METHODS AND COMPOSITIONS OF CYTOTOXIC T CELL DEPLETION Filling date: 13 Sep 2025 Issue date: 11 Mar 2021 |
Application | Utility: METHODS AND COMPOSITIONS FOR TREATING CANCER Filling date: 13 Sep 2025 Issue date: 4 Mar 2021 |
Application | Utility: NOVEL RNA-PROGRAMMABLE ENDONUCLEASE SYSTEMS AND USES THEREOF Filling date: 13 Sep 2025 Issue date: 25 Feb 2021 |
Application | Utility: SELF-INACTIVATING (SIN) CRISPR/CAS OR CRISPR/CPF1 SYSTEMS AND USES THEREOF Filling date: 13 Sep 2025 Issue date: 4 Feb 2021 |
Application | Utility: METHODS AND COMPOSITIONS FOR IMPROVED HOMOLOGY DIRECTED REPAIR Filling date: 13 Sep 2025 Issue date: 14 Jan 2021 |
Application | Utility: MATERIALS AND METHODS FOR ENGINEERING CELLS AND USES THEREOF IN IMMUNO-ONCOLOGY Filling date: 13 Sep 2025 Issue date: 31 Dec 2020 |
Application | Utility: MATERIALS AND METHODS FOR ENGINEERING CELLS AND USES THEREOF IN IMMUNO-ONCOLOGY Filling date: 13 Sep 2025 Issue date: 31 Dec 2020 |
Application | Utility: MATERIALS AND METHODS FOR CONTROLLING GENE EDITING Filling date: 13 Sep 2025 Issue date: 31 Dec 2020 |
Application | Utility: MATERIALS AND METHODS FOR TREATMENT OF AUTOSOMAL DOMINANT CONE-ROD DYSTROPHY Filling date: 13 Sep 2025 Issue date: 10 Dec 2020 |
Application | Utility: GENE EDITING FOR HEMOPHILIA A WITH IMPROVED FACTOR VIII EXPRESSION Filling date: 13 Sep 2025 Issue date: 10 Dec 2020 |
Application | Utility: NOVEL RNA-PROGRAMMABLE ENDONUCLEASE SYSTEMS AND THEIR USE IN GENOME EDITING AND OTHER APPLICATIONS Filling date: 13 Sep 2025 Issue date: 10 Dec 2020 |
Application | Utility: MATERIALS AND METHODS FOR TREATMENT OF USHER SYNDROME TYPE 2A Filling date: 13 Sep 2025 Issue date: 12 Nov 2020 |
Application | Utility: GENE-EDITING SYSTEMS FOR MODIFYING A SCN9A OR SCN10A GENE AND METHODS OF USE THEREOF Filling date: 13 Sep 2025 Issue date: 12 Nov 2020 |
Application | Utility: UNIVERSAL DONOR CELLS Filling date: 13 Sep 2025 Issue date: 5 Nov 2020 |
Application | Utility: UNIVERSAL DONOR CELLS Filling date: 13 Sep 2025 Issue date: 5 Nov 2020 |
Application | Utility: MATERIALS AND METHODS FOR ENGINEERING CELLS AND USES THEREOF IN IMMUNO-ONCOLOGY Filling date: 13 Sep 2025 Issue date: 22 Oct 2020 |
Application | Utility: MATERIALS AND METHODS FOR TREATMENT OF AUTOSOMAL DOMINANT RETINITIS PIGMENTOSA Filling date: 13 Sep 2025 Issue date: 22 Oct 2020 |
Application | Utility: MATERIALS AND METHODS FOR TREATMENT OF HEMOGLOBINOPATHIES Filling date: 13 Sep 2025 Issue date: 22 Oct 2020 |
Application | Utility: MATERIALS AND METHODS FOR TREATMENT OF USHER SYNDROME TYPE 2A AND/OR NON-SYNDROMIC AUTOSOMAL RECESSIVE RETINITIS PIGMENTOSA (ARRP) Filling date: 13 Sep 2025 Issue date: 8 Oct 2020 |
Application | Utility: COMPOSITIONS AND METHODS FOR TREATMENT OF PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9)-RELATED DISORDERS Filling date: 13 Sep 2025 Issue date: 6 Aug 2020 |
Application | Utility: ANTI-LIV1 IMMUNE CELL CANCER THERAPY Filling date: 13 Sep 2025 Issue date: 23 Jul 2020 |
Application | Utility: MATERIALS AND METHODS FOR TREATMENT OF SPINOCEREBELLAR ATAXIA TYPE 2 (SCA2) AND OTHER SPINOCEREBELLAR ATAXIA TYPE 2 PROTEIN (ATXN2) GENE RELATED CONDITIONS OR DISORDERS Filling date: 13 Sep 2025 Issue date: 9 Jul 2020 |
Application | Utility: COMPOSITIONS AND METHODS FOR GENE EDITING Filling date: 13 Sep 2025 Issue date: 21 May 2020 |
Application | Utility: ANTI-PTK7 IMMUNE CELL CANCER THERAPY Filling date: 13 Sep 2025 Issue date: 7 May 2020 |
Application | Utility: MATERIALS AND METHODS FOR TREATMENT OF APOLIPOPROTEIN C3 (APOCIII)-RELATED DISORDERS Filling date: 13 Sep 2025 Issue date: 23 Apr 2020 |
Application | Utility: MATERIALS AND METHODS FOR TREATMENT OF MEROSIN-DEFICIENT COGENITAL MUSCULAR DYSTROPHY (MDCMD) AND OTHER LAMININ, ALPHA 2 (LAMA2) GENE RELATED CONDITIONS OR DISORDERS Filling date: 13 Sep 2025 Issue date: 26 Mar 2020 |
Application | Utility: UNIVERSAL DONOR CELLS Filling date: 13 Sep 2025 Issue date: 12 Mar 2020 |
Application | Utility: UNIVERSAL DONOR CELLS Filling date: 13 Sep 2025 Issue date: 12 Mar 2020 |
Application | Utility: MATERIALS AND METHODS FOR TREATMENT OF PRIMARY HYPEROXALURIA TYPE 1 (PH1) AND OTHER ALANINE-GLYOXYLATE AMINOTRANSFERASE (AGXT) GENE RELATED CONDITIONS OR DISORDERS Filling date: 13 Sep 2025 Issue date: 12 Mar 2020 |
Application | Utility: METHODS AND COMPOSITIONS FOR TREATING CANCER Filling date: 13 Sep 2025 Issue date: 27 Feb 2020 |
Application | Utility: COMPOSITIONS AND METHODS FOR GENOMIC EDITING BY INSERTION OF DONOR POLYNUCLEOTIDES Filling date: 13 Sep 2025 Issue date: 6 Feb 2020 |
Application | Utility: MATERIALS AND METHODS FOR TREATMENT OF EARLY ONSET PARKINSON'S DISEASE (PARK1) AND OTHER SYNUCLEIN, ALPHA (SNCA) GENE RELATED CONDITIONS OR DISORDERS Filling date: 13 Sep 2025 Issue date: 6 Feb 2020 |
Application | Utility: MATERIALS AND METHODS FOR TREATMENT OF GLYCOGEN STORAGE DISEASE TYPE 1A Filling date: 13 Sep 2025 Issue date: 19 Dec 2019 |
Application | Utility: MATERIALS AND METHODS FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY Filling date: 13 Sep 2025 Issue date: 12 Dec 2019 |
Application | Utility: MATERIALS AND METHODS FOR ENGINEERING CELLS AND USES THEREOF IN IMMUNO-ONCOLOGY Filling date: 13 Sep 2025 Issue date: 5 Dec 2019 |
Application | Utility: MATERIALS AND METHODS FOR ENGINEERING CELLS AND USES THEREOF IN IMMUNO-ONCOLOGY Filling date: 13 Sep 2025 Issue date: 5 Dec 2019 |
Application | Utility: MATERIALS AND METHODS FOR TREATMENT OF DYSTROPHIC EPIDERMOLYSIS BULLOSA (DEB) AND OTHER COLLAGEN TYPE VII ALPHA 1 CHAIN (COL7A1) GENE RELATED CONDITIONS OR DISORDERS Filling date: 13 Sep 2025 Issue date: 5 Dec 2019 |
Application | Utility: METHODS AND COMPOSITIONS FOR EFFICIENT GENE DELETION Filling date: 13 Sep 2025 Issue date: 28 Nov 2019 |
Application | Utility: MATERIALS AND METHODS FOR TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS) AND OTHER RELATED DISORDERS Filling date: 13 Sep 2025 Issue date: 31 Oct 2019 |
Application | Utility: MATERIALS AND METHODS FOR ENGINEERING CELLS AND USES THEREOF IN IMMUNO-ONCOLOGY Filling date: 13 Sep 2025 Issue date: 17 Oct 2019 |
Application | Utility: MATERIALS AND METHODS FOR ENGINEERING CELLS AND USES THEREOF IN IMMUNO-ONCOLOGY Filling date: 13 Sep 2025 Issue date: 17 Oct 2019 |
Application | Utility: MATERIALS AND METHODS FOR TREATMENT OF HEMOGLOBINOPATHIES Filling date: 13 Sep 2025 Issue date: 19 Sep 2019 |
Application | Utility: MATERIALS AND METHODS FOR TREATMENT OF HEMOGLOBINOPATHIES Filling date: 13 Sep 2025 Issue date: 22 Aug 2019 |
Application | Utility: MATERIALS AND METHODS FOR TREATMENT OF PAIN RELATED DISORDERS Filling date: 13 Sep 2025 Issue date: 25 Jul 2019 |
Showing 50 to 98 of 98 patents.